This article relies on a single source. (May 2024) |
| Names | |
|---|---|
| IUPAC name
1-(2-Methoxyphenoxy)-3-(propan-2-ylamino)propan-2-ol | |
| Other names
(±)-Moprolol | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
| ECHA InfoCard | 100.024.777 |
| EC Number |
|
| MeSH | C009976 |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C13H21NO3 | |
| Molar mass | 239.315 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Moprolol is a beta-adrenergic antagonist, or beta blocker. It is typically prescribed to treat hypertension, high blood pressure, angina pectoris, arrhythmias, anxiety, and glaucoma.
Moprolol is currently off the market, most likely due to the manufacturer being in violation of US good manufacturing practices.